Literature DB >> 24220080

Field efficacy and acceptability of PermaNet® 3.0 and OlysetNet® in Kinshasa, Democratic Republic of the Congo.

Thierry Bobanga1, Wycliff Ayieko, Mimie Zanga, Solange Umesumbu, Ange Landela, Olivier Fataki, Alain Serge Mandoko, Jacques Tshibamba, Lambert Nyabola.   

Abstract

BACKGROUND &
OBJECTIVES: Insecticide resistance in mosquitoes at Kinshasa may jeopardize the efficacy and usage of long-lasting insecticidal nets (LLINs). Entomological impact, user acceptance and bioefficacy of a combination LLIN (PermaNet® 3.0) and a standard LLIN (OlysetNet®) were evaluated at two sites in Kinshasa characterized by high densities of either Anopheles gambiae s.s. (Kindele) or Culex spp (Kimbangu).
METHODS: Insecticide susceptibility (permethrin, deltamethrin, bendiocarb, propoxur and DDT) was determined via tube tests and bottle assays. Entomological impact of unwashed and washed LLINs and untreated nets was assessed via Latin square, based on rotation of nets and their users through selected houses at each site. User acceptability was evaluated through interviews using a questionnaire and net bioefficacy was measured via cone bioassays with field-derived An. gambiae s.s.
RESULTS: The An. gambiae s.s. population from Kindele was resistant to DDT and permethrin with mortality rate of 27.3 and 75.8%, respectively, and kdr mutations (L1014F) plus suspected metabolic resistance. The Culex spp population was resistant to all five insecticides tested. No differences in entomological indices were observed for the five net treatments, but bioefficacy against An. gambiae was significantly higher for unwashed and washed PermaNet 3.0 (100 and 71% mortality) than for OlysetNet (56 and 36%). Householders reported a good sleep most often when using unwashed and washed PermaNet (94 and 88%) and least often with unwashed OlysetNet (46%). INTERPRETATION &
CONCLUSION: High bioefficacy via cone bioassays against an An. gambiae s.s. population with kdr and suspected metabolic resistance was observed with PermaNet 3.0. Lower biting rates and a higher chance of a good night of sleep were reported when using PermaNet 3.0 compared to OlysetNet.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24220080

Source DB:  PubMed          Journal:  J Vector Borne Dis        ISSN: 0972-9062            Impact factor:   1.688


  5 in total

1.  High Plasmodium Infection Rate and Reduced Bed Net Efficacy in Multiple Insecticide-Resistant Malaria Vectors in Kinshasa, Democratic Republic of Congo.

Authors:  Jacob M Riveron; Francis Watsenga; Helen Irving; Seth R Irish; Charles S Wondji
Journal:  J Infect Dis       Date:  2018-01-04       Impact factor: 5.226

2.  Insecticide resistance in Anopheles gambiae from the northern Democratic Republic of Congo, with extreme knockdown resistance (kdr) mutation frequencies revealed by a new diagnostic assay.

Authors:  Amy Lynd; Ambrose Oruni; Arjen E Van't Hof; John C Morgan; Leon Bwazumo Naego; Dimitra Pipini; Kevin A O'Kines; Thierry L Bobanga; Martin J Donnelly; David Weetman
Journal:  Malar J       Date:  2018-11-06       Impact factor: 2.979

3.  Piperonyl butoxide (PBO) combined with pyrethroids in insecticide-treated nets to prevent malaria in Africa.

Authors:  Katherine Gleave; Natalie Lissenden; Marty Richardson; Leslie Choi; Hilary Ranson
Journal:  Cochrane Database Syst Rev       Date:  2018-11-29

4.  Effect of individual and community-level bed net usage on malaria prevalence among under-fives in the Democratic Republic of Congo.

Authors:  Lauren Levitz; Mark Janko; Kashamuka Mwandagalirwa; Kyaw L Thwai; Joris L Likwela; Antoinette K Tshefu; Michael Emch; Steven R Meshnick
Journal:  Malar J       Date:  2018-01-18       Impact factor: 2.979

5.  Nationwide insecticide resistance status and biting behaviour of malaria vector species in the Democratic Republic of Congo.

Authors:  Francis Wat'senga; Emile Zola Manzambi; Andre Lunkula; Roger Mulumbu; Tania Mampangulu; Neil Lobo; Allison Hendershot; Christen Fornadel; Djenam Jacob; Mame Niang; Ferdinand Ntoya; Tamfum Muyembe; Joris Likwela; Seth R Irish; Richard M Oxborough
Journal:  Malar J       Date:  2018-03-27       Impact factor: 2.979

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.